Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral erythromycin ethyl succinate for establishment of feeding in preterm infants
IRCT2015121925591N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of erythromycin in feeding intolerance and preterm birth, sponsored by Iran University of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
erythromycin
03
Conditions
feeding intolerancepreterm birth
Beyond the preview
Go deeper on IRCT2015121925591N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015121925591N1.